Hinge Health Targets $2.6 Billion Valuation in NYSE IPO

In-Depth Analysis

Hinge Health, founded in 2014, offers software-based physical therapy for acute musculoskeletal injuries, chronic pain, and post-surgery rehabilitation. The company's IPO is closely watched as a bellwether for the digital health industry.

The company's revenue growth demonstrates increasing demand for remote physical therapy solutions. In the first quarter, revenue climbed 50% to $123.8 million, up from $82.7 million during the same period last year. Hinge reported $117.3 million in revenue during its fourth quarter, up 44% from the same period in 2023.

The IPO is led by Morgan Stanley, Barclays Capital, and BofA Securities.

Actionable Takeaways: - Monitor the performance of Hinge Health's stock (HNGE) to gauge investor sentiment towards digital health companies. - Explore digital physical therapy solutions for remote rehabilitation and chronic pain management.

Read source article

FAQ

What is Hinge Health's business?

Hinge Health provides digital physical therapy solutions for musculoskeletal injuries and chronic pain.

What is the expected valuation for Hinge Health's IPO?

Hinge Health is targeting a valuation of up to $2.6 billion.

What exchange will Hinge Health be listed on?

The company will list on the New York Stock Exchange (NYSE) under the ticker symbol "HNGE."

Takeaways

Hinge Health's IPO is a major event for the digital health industry.
The company's revenue growth indicates strong demand for remote physical therapy.
Keep an eye on Hinge Health's stock performance as an indicator of the digital health market's strength.

Discussion

Do you think Hinge Health's IPO will be successful? How will this impact the digital health industry? Share this article with others who need to stay ahead of this trend!

Sources

Hinge Health aims to raise up to $437 million in IPO, pricing at $28.00 to $32.00 per share Physio App Maker Hinge Health, Backers Seek $437 Million in IPO Hinge Health targets $2.6 billion valuation in NYSE IPO

Disclaimer

This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.

All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.

This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.

Always do your own research (DYOR) before making any decisions based on the information presented.